Melrose, the engineering company, has set its sights on spending up to £2bn on acquiring an underperforming manufacturer, probably based in the US and UK.

Assuming the deal comes off, it would be a furthertest for Melrose's unusual model of applying techniques related to those used in private equity to turn round "sick" businesses, although via the framework of a listed company.